retatrutide type 2 diabetes phase 2 results Lilly's triple agonist, retatrutide, successful in two additional 3 obesity trials, delivering significant improvements in weight and A1C VisualAbstract: Retatrutide reduces body weight
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31


01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)


















